Approval · Notice of Compliance 21406 · 2018
XERMELO: Notice of Compliance 21406
Issued October 10, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21406
- Date
- October 10, 2018
- Company
- Ipsen Biopharmaceuticals Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XERMELO | 02481553 | Marketed |
Medicinal ingredients
- TELOTRISTAT ETIPRATE 250 MG per TAB